MSTT1041A (Astegolimab)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MSTT1041A (Astegolimab), covering 2022-01-10 to 2022-01-10. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia [Phase 2]